Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis

Abstract Introduction Patients with ankylosing spondylitis (AS) have significant unmet treatment needs, despite advancements in biologic therapies. This study evaluated the impact of upadacitinib on clinically meaningful improvement in patient-reported outcomes (PROs) assessing disease activity, pai...

詳細記述

書誌詳細

出版年:	Rheumatology and Therapy
主要な著者:	Victoria Navarro-Compán, Xenofon Baraliakos, Marina Magrey, Andrew Östör, Christopher D. Saffore, Manish Mittal, In-Ho Song, Fabiana Ganz, Jayne Stigler, Atul Deodhar
フォーマット:	論文
言語:	英語
出版事項:	Adis, Springer Healthcare 2023-02-01
主題:	Ankylosing spondylitis Axial spondyloarthritis Patient-reported outcomes Health-related quality of life Upadacitinib
オンライン･アクセス:	https://doi.org/10.1007/s40744-023-00536-2